

Cover Story
Conversation with The Cancer Letter
When Naoto T. Ueno left MD Anderson to become director of the University of Hawaiʻi Cancer Center, he took one of the most challenging jobs in oncology.
In Brief
Funding Opportunities
Clinical Roundup


Drugs & Targets


Trending Stories
- Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Bhattacharya cancels NIH all-hands meeting
- In the Headlines: “There’s no one to stand up for NCI right now.”
- An opportunity for Trump: Position U.S. cancer science to lead the world
- Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies